Navigate this market better. Subscribe for FREE stock alerts and information.

Wednesday, August 27, 2014

Delaware judge fast-tracks Valeant, Pershing lawsuit over Allergan special meeting, (NYSE: AGN), (NYSE: VRX), (TSE: VRX.TO)

A Delaware judge granted a request by Valeant Pharmaceuticals International Inc and Pershing Square Capital Management for expedited proceedings in a special meeting dispute with Allergan Inc. Andre Bouchard of Delaware's Court of Chancery scheduled a three-day trial to start Oct. 6. Allergan had proposed a Nov. 24 trial.

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 0.1% or $-0.16/share to $163.81. In the past year, the shares have traded as low as $86.95 and as high as $174.49. On average, 2748930 shares of AGN exchange hands on a given day and today's volume is recorded at 310113.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.14% or $0.16/share to $117.26. In the past year, the shares have traded as low as $95.28 and as high as $153.10. On average, 3243810 shares of VRX exchange hands on a given day and today's volume is recorded at 525367.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.51% or $-0.66/share to $127.56. In the past year, the shares have traded as low as $99.90 and as high as $170.45. On average, 352237 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 45452.



Source